1. Home
  2. TCI vs ABEO Comparison

TCI vs ABEO Comparison

Compare TCI & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCI
  • ABEO
  • Stock Information
  • Founded
  • TCI 1983
  • ABEO 1974
  • Country
  • TCI United States
  • ABEO United States
  • Employees
  • TCI N/A
  • ABEO N/A
  • Industry
  • TCI Real Estate
  • ABEO Biotechnology: Pharmaceutical Preparations
  • Sector
  • TCI Finance
  • ABEO Health Care
  • Exchange
  • TCI Nasdaq
  • ABEO Nasdaq
  • Market Cap
  • TCI 239.1M
  • ABEO 256.9M
  • IPO Year
  • TCI N/A
  • ABEO 1980
  • Fundamental
  • Price
  • TCI $43.27
  • ABEO $5.85
  • Analyst Decision
  • TCI
  • ABEO Strong Buy
  • Analyst Count
  • TCI 0
  • ABEO 6
  • Target Price
  • TCI N/A
  • ABEO $18.00
  • AVG Volume (30 Days)
  • TCI 6.9K
  • ABEO 1.1M
  • Earning Date
  • TCI 08-07-2025
  • ABEO 08-11-2025
  • Dividend Yield
  • TCI N/A
  • ABEO N/A
  • EPS Growth
  • TCI 59.61
  • ABEO N/A
  • EPS
  • TCI 0.92
  • ABEO N/A
  • Revenue
  • TCI $47,452,000.00
  • ABEO N/A
  • Revenue This Year
  • TCI N/A
  • ABEO N/A
  • Revenue Next Year
  • TCI N/A
  • ABEO $323.51
  • P/E Ratio
  • TCI $47.13
  • ABEO N/A
  • Revenue Growth
  • TCI N/A
  • ABEO N/A
  • 52 Week Low
  • TCI $25.50
  • ABEO $3.93
  • 52 Week High
  • TCI $46.74
  • ABEO $7.32
  • Technical
  • Relative Strength Index (RSI)
  • TCI 55.51
  • ABEO 47.54
  • Support Level
  • TCI $42.80
  • ABEO $5.68
  • Resistance Level
  • TCI $46.23
  • ABEO $5.93
  • Average True Range (ATR)
  • TCI 1.46
  • ABEO 0.26
  • MACD
  • TCI -0.36
  • ABEO -0.01
  • Stochastic Oscillator
  • TCI 35.50
  • ABEO 56.25

About TCI Transcontinental Realty Investors Inc.

Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Share on Social Networks: